Clinical Trial

Multi-Strain Probiotics Supplementation With Standard Care in Mild to Moderate Ulcerative Colitis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 12, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
Probiotics are one of the adjunctive treatments that have been extensively explored for Ulcerative colitis (UC) disease management. Probiotics, a group of beneficial bacteria, can bring various health benefits when adequately supplied to the body, especially for gut wellness. In particular, for UC patients, gut dysbiosis is one of the contributing factors in their pathogenesis. Thus, the supplementation of probiotics in combination with standard treatment can potentially help in relieving symptoms as well as promoting mucosal healing for long-term remission.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-11.
Trial Details
NCT Number NCT06595719
Lead Sponsor National University of Malaysia
Conditions Ulcerative Colitis
Enrollment 124 participants
Start Date 2024-02-23
Primary Completion 2026-01 (estimated)
Study Completion 2026-02 (estimated)
Updated on ClinicalTrials.gov 2025-03-12